Comments
Loading...
UroGen Pharma (NASDAQ:URGN) Stock, Earnings Estimates, EPS, And Revenue
UroGen Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$-0.780
Quarterly Revenue Estimate
$29.42 M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$89.36 M
Analyze the earnings history of UroGen Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
UroGen Pharma (URGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $-0.55 | $-0.82 | 32.9 % |
| Jun 2024 | 2024-08-13 | $-0.91 | $-0.84 | -8.33 % |
| Mar 2024 | 2024-05-13 | $-0.97 | $-0.87 | -11.5 % |
| Dec 2023 | 2024-03-14 | $-0.72 | $-0.68 | -5.88 % |
UroGen Pharma (URGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $25.20M | $24.20M | 4.15 % |
| Jun 2024 | 2024-08-13 | $21.85M | $23.76M | -8.05 % |
| Mar 2024 | 2024-05-13 | $18.78M | $21.38M | -12.2 % |
| Dec 2023 | 2024-03-14 | $23.53M | $22.57M | 4.25 % |
FAQ
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma (URGN) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for UroGen Pharma (NASDAQ:URGN)?
The Actual EPS was $-0.55, which beat the estimate of $-0.82.
What were UroGen Pharma’s (NASDAQ:URGN) revenues?
The Actual Revenue was $25.2M, which beat the estimate of $24.2M.
Browse earnings estimates, EPS, and revenue on all stocks.